A trend toward significance was observed for penta‐drug refractoriness.
← all excerpts
A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma.
2
—
—
The sentences
In the multivariate model, ECOG ≥ 2, extraosseous disease, and ISS III showed a trend toward significance (Table 3 and Figure 2F,G ).